venusinbont.nl

A New Form of Glutamate Signaling Discovered in Migraine – Discovery and Innovation at University of Utah Health

5 (450) · € 14.00 · En Stock

Biomedicines, Free Full-Text

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo

Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo

Frontiers Glutamate Signaling in Healthy and Diseased Bone

IJMS, Free Full-Text

63rd Annual Scientific Meeting American Headache Society® - 2021 - Headache: The Journal of Head and Face Pain - Wiley Online Library

A New Form of Glutamate Signaling Discovered in Migraine – Discovery and Innovation at University of Utah Health

American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado - 2022 - Headache: The Journal of Head and Face Pain - Wiley Online Library

Genome-wide association analysis identifies susceptibility loci for migraine without aura

JVD, Free Full-Text

Pharmacological targeting of glutamatergic neurons within the brainstem for weight reduction